Evidence map›Paper›PMID 35424368›Full record

ArticleRSC advances2021

Rapid synthesis of internal peptidyl α-ketoamides by on resin oxidation for the construction of rhomboid protease inhibitors.

Tim Van Kersavond, Raphael Konopatzki, Merel A T van der Plassche, Jian Yang, Steven H L Verhelst

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Tim Van KersavondLeibniz Institute for Analytical Sciences ISAS e.V., Otto-Hahn-Str. 6b 44227 Dortmund Germany.
Raphael KonopatzkiLeibniz Institute for Analytical Sciences ISAS e.V., Otto-Hahn-Str. 6b 44227 Dortmund Germany.
Merel A T van der PlasscheKU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Chemical Biology Herestr. 49 box 802 3000 Leuven Belgium steven.verhelst@kuleuven.be.
Jian YangKU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Chemical Biology Herestr. 49 box 802 3000 Leuven Belgium steven.verhelst@kuleuven.be.
Steven H L VerhelstLeibniz Institute for Analytical Sciences ISAS e.V., Otto-Hahn-Str. 6b 44227 Dortmund Germany.ORCID 0000-0002-7400-1319
Leibniz Institute for Analytical Sciences - ISAS · DENOAA Chemical Sciences Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhomboid proteases are intramembrane serine proteases, which are involved in a wide variety of biological processes and have been implied in various human diseases. Recently, peptidyl α-ketoamides have been reported as rhomboid inhibitors with high potency and selectivity - owing to their interaction with both the primed and non-primed site of the target protease. However, their synthesis has been performed by solution phase chemistry. Here, we report a solid phase strategy towards ketoamides as rhomboid protease inhibitors, allowing rapid synthesis and optimization. We found that the primed site binding part of inhibitors is crucial for potency.

Identifiers

PMID35424368
PMCPMC8694341
OpenAlexW4238359365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.